Cardiology

Ivabradine improves angina-related quality of life

(HealthDay)—For patients with angina pectoris, ivabradine is associated with improvements in certain parameters of quality of life (QoL), according to a study published online Dec. 22 in Circulation: Cardiovascular Quality ...

Cardiology

Lixisenatide doesn't affect cardiovascular risk in T2DM

(HealthDay)—The addition of lixisenatide to usual care does not impact the rate of major cardiovascular events or other serious adverse events among patients with type 2 diabetes and a recent acute coronary syndrome, according ...

Cardiology

Device used in europe promising for refractory angina

(HealthDay)—A stent-like device placed in the coronary sinus may benefit patients with refractory angina, according to a small clinical trial published in the Feb. 5 issue of the New England Journal of Medicine. The Reducer ...

page 4 from 10